三线抗逆转录病毒治疗登记册，以跟踪患者的临床和病毒学结果。
A third-line antiretroviral therapy register to track patient clinical and virological outcomes.
机构信息
Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
出版信息
S Afr Med J. 2022 Aug 2;112(8):511.
PMID:36214397
Abstract
In 2021, South Africa (SA) had an estimated 7.8 million people living with HIV, of whom 5.6 million were receiving antiretroviral therapy (ART),[1] with 3.4 million on first-line ART, 145 000 on second-line ART (SLART) and >700 on third-line ART (TLART).
摘要
2021 年，南非（SA）估计有 780 万人感染艾滋病毒，其中 560 万人正在接受抗逆转录病毒治疗（ART），[1]其中 340 万人使用一线 ART，14.5 万人使用二线 ART（SLART），超过 700 人使用三线 ART（TLART）。
Zotero 插件